Abstract
The separation of 6-APA from its side chain by amidase (fig. 1) has allowed a very wide variety of new side chains to be attached to the nucleus semi-synthetically giving rise to different therapeutic properties, including acid resistance as with the Phenoxymethylpenicillins, penicillinase resistance as with methicillin and the isoxazolyl penicillins, and a wider antibacterial spectrum as with ampicillin, amoxycillin, epicillin, hetacillin and carbenicillin (fig. 2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baldwin, D.S.; Levine, B.B.; McCluskey, R.T. and Gallo, G.R.: Renal failure and interstitial nephritis due to penicillin and methicillin. New England Journal of Medicine 279: 1245–1252 (1968).
Bear, D.M.; Turck, M. and Petersdorf, R.G.: Ampicillin. Medical Clinics of North America 54: 1145–1159(1970).
Bond, J.M.; Lightbrown, J.W.; Barber, M. and Waterworth, P.M.: Four phenoxypenicillins. British Medical Journal 2: 956–961 (1963).
Brauninger, G.E. and Remington, J.S.: Neuropathy associated with methicillin therapy. Journal of the American Medical Association 203: 103–105 (1968).
Brogden, R.N. and Avery, G.S.: New Antibiotics: Epicillin, minocycline and spectinomycin. A summary of their antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 3: 314–330(1972).
Brogden, R.N.; Speight, T.M. and Avery, G.S.: Amoxycillin: A review of its antibacterial and pharmacokinetic properties and therapeutic use. Drugs 9: 88–140 (1975).
Cameron, S.J. and Richmond, J.-. Ampicillin hypersensitivity in lymphatic leukaemia. Scottish Medical Journal 16: 425–427 (1971).
Clayton, J.P.; Cole, M.; Elson, S.W. and Ferres, H.: BRL 8988 (talampicillin), a well-absorbed oral form of ampicillin. Antimicrobial Agents and Chemotherapy 5: 670–671 (1974).
Clymo, A.B. and Harper, I.A.: Ampicillin-resistant Haemophilus influenzae meningitis. Lancet 1: 453–454(1974).
Collaborative Study Group: Prospective study of ampicillin rash. British Medical Journal 1: 7–9 (1973).
Daehne, W.V.; Godtfredsen, W.O.; Roholt, K. and Tybring, L.: Pivampicillin, a new orally active ampicillin ester. Antimicrobial Agents and Chemotherapy 1970, p.431 (1971).
Dahnsjo, H.; Andersson, H.; Hallander, H.O. and Rudberg, R.D.: Tone audiometry control of children treated for meningitis with large intravenous doses of ampicillin. Acta Paediatrica Scandinavica 65: 733–737(1976).
Garrod, L.P.; Lambert, H.P. and O’Grady, F.: in Antibiotic and Chemotherapy, 4th ed, p.72 and 76 (Churchill Livingstone, Edinburgh and London 1973).
Gilbert, D.N. and Sanford, J.P.: Methicillin. Critical appraisal after a decade of experience. Medical Clinics of North America 54: 1113–1125 (1970).
Hambleton, G. and Davies, Pamela A.: Diagnosis and management of bacterial meningitis. Drugs 8: 15–53(1974).
Heineman, H.S. and Israel, W.: Carbenicillin in the first nine months of unrestricted use. A chapter in the natural history of an antibiotic. Journal of Clinical Pharmacology 12: 241–248 (1972).
Hewitt, W.L. and Winters, R.E.: The current status of parenteral carbenicillin. Journal of Infectious Diseases 127: 120–129(1973).
Kjellander, J.O. and Finland, M.: Studies of the penicillinase of Staphylococcus albus. Proceedings of the Society for Experimental Biology (N.Y.) 113: 1031–1037 (1963).
Knudsen, E.T. and Harding, J.W.: A multicentre comparative trial of talampicillin and ampicillin in general practice. British Journal of Clinical Practice 29: 255–266 (1975).
Lacey, R.: A new type of penicillin resistance of Staphylococcus aureus? Journal of Antimicrobial Chemotherapy 3: 380–381 (1977).
Leading Article: An oral carbenicillin. British Medical Journal 3: 555–556 (1973).
Leading Article: Haemophilus influenzae. Lancet 2: 116–111 (1976).
Levitt, B.H.; Gottlieb, A.J.; Rosenberg, I.R. and Klein, J.J.: Bone marrow depression due to methicillin, a semisynthetic penicillin. Clinical Pharmacology and Therapeutics 5: 301–306 (1964).
Marcy, S.M. and Klein, J.O.: The Isoxazolyl Penicillins: Oxacillin, Cloxacillin and Dicloxacillin. Medical Clinics of North America 54: 1127–1143 (1970).
May, J.R. and Ingold, A.: Amoxicillin in the treatment of infections of the lower respiratory tract. Journal of Infectious Diseases 129 (Suppl. June): 189–193 (1974).
Neu, H.C.: Antimicrobial activity and human pharmacology of amoxycillin. Journal of Infectious Diseases 129 (Suppl): 123–131 (1974).
Parker, M.T. and Hewitt, J.H.: Methicillin resistance in Staphylococcus aureus. Lancet 1: 800–804 (1970).
Pullen, H.; Wright, N. and Murdoch, J. McC.: Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis. Lancet 2: 1176–1178 (1967).
Rolinson, G.N.; Stevens, S.; Batchelor, F.R.; Wood, J.C. and Chain, E.B.: Bacteriological studies on a new penicillin BRL 1241. Lancet 2: 564–567 (1960).
Schiffer, M.S.; MacLowry, J.; Schneerson, R.; Robbins, J.B.; McReynolds, J.W.; Thomas, W.J.; Bailey, D.W.; Clarke, E.J.; Mueller, E.J. and Escamilla, J.: Clinical, bacteriological and immunological characterisation of ampicillin-resistant Haemophilus influenzae type B. Lancet 2: 257–259 (1974).
Sutherland, R. and Rolinson, G.N.: Characteristics of methicillin-resistant staphylococci. Journal of Bacteriology 87: 887–899(1964).
Sutherland, R.; Croydon, E.A.P. and Rolinson, G.N.: Amoxycillin: a new semi-synthetic penicillin. British Medical Journal 3: 13–16 (1972).
Swarz, H. and Storari, F.E.: Indanyl carbenicillin. Excerpta Medica (1974).
The Medical Letter on Drugs and Therapeutics: Hetacillin 13: 49–50 (Issue 324) (1971).
Turk, D.C.: Ampicillin-resistant Haemophilus influenzae meningitis. Lancet 1: 453 (1974).
Wilcox, J.B.; Brogden, R.N. and Avery, G.S.: Pivampicillin: A preliminary report of its pharmacokinetic properties and therapeutic efficacy. Drugs 6: 94–103 (1973).
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1978 ADIS Press
About this chapter
Cite this chapter
Ball, A.P., Gray, J.A., Murdoch, J.M. (1978). The Semi-synthetic Penicillins. In: Antibacterial Drugs Today. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-8004-7_4
Download citation
DOI: https://doi.org/10.1007/978-94-011-8004-7_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-85200-505-7
Online ISBN: 978-94-011-8004-7
eBook Packages: Springer Book Archive